HRMY
Harmony Biosciences Holdings, Inc.
30.47
USD
This page is just a preview of the data found in TrendSpider’s full version
Harmony Biosciences Holdings, Inc. stock is up 23.71% since 30 days ago. The next earnings date is Feb 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November. In the last 9 Unusual Options Trades, there were 9 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 13 Oct 13:44 | 19 Apr, 2024 | 45.00 | 530 | ||
| 20 Oct 14:23 | 20 Oct, 2023 | 40.00 | 40 | ||
| 20 Oct 14:23 | 20 Oct, 2023 | 40.00 | 40 | ||
| 31 Oct 17:09 | 19 Jan, 2024 | 30.00 | 337 | ||
| 30 Nov 14:51 | 19 Apr, 2024 | 40.00 | 26 | ||
| 30 Nov 14:54 | 19 Apr, 2024 | 40.00 | 26 | ||
| 30 Nov 14:55 | 19 Apr, 2024 | 45.00 | 737 | ||
| 01 Dec 15:46 | 19 Jan, 2024 | 35.00 | 91 | ||
| 01 Dec 17:12 | 19 Apr, 2024 | 35.00 | 25 |
Harmony Biosciences Holdings, Inc. develops and commercializes therapies for patients with rare neurological disorders in the United States. WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
